How should healthcare providers approach GLP-1 Agonists (Ozempic, Wegovy, etc.)?
After the boom in usage of weight loss inhibitors last year by the likes of Ozempic, Wegovy, Mounjaro and more, it's time to take a step back and look at how these new medications have changed our healthcare landscape.
July 18, 2024 | Brendan Copley, CSCS, ATC | Ashley Jerry, MS
After the boom in usage of weight loss inhibitors last year by the likes of Ozempic, Wegovy, Mounjaro and more, it's time to take a step back and look at how these new medications have changed our healthcare landscape.
Personal Trainer Brendan Copley, CSCS, ATC, and Nutritionist Ashley Jerry, MS, tackle the important questions of who should be taking these GLP-1 Agonist medications, concerns to watch out for, what to think about when coming and off the medication, and finally, what other healthy habits should be incorporated into the process to ensure clients stay healthy and achieve the results they were looking for.
Listen here, or wherever you get your podcasts.
